Navigation Links
Agility Clinical Expands Consulting Services to More Broadly Serve Small and Virtual Biopharma and Device Companies
Date:11/8/2012

CARLSBAD, Calif., Nov. 8, 2012 /PRNewswire/ -- Agility Clinical, Inc., a specialty consulting and clinical research organization, has expanded its stand-alone consulting services to more broadly serve the unmet needs of small and virtual biopharma and device companies. The firm helps pre-clinical and clinical stage companies with a lean infrastructure develop drugs and devices by providing strategic and operational consulting support, in addition to traditional CRO services.

"Seasoned industry expertise is essential to deliver value to a sophisticated life science client, and we are very excited to have been able to assemble such a talented and experienced group of individuals.  We can provide expert strategic and operational consulting support to our clients at all stages of clinical development," says Ellen Morgan, CEO of Agility and a 30-year industry veteran. "Agility provides a centralized location where companies can get sound advice that is often vital to their clinical development plans with the ability to respond rapidly to changes and challenges."  Morgan co-founded and was CEO and chairman of Synteract, Inc., a California-based CRO that grew to over 300 employees and provided clinical services to hundreds of companies during her tenure.

Responding to requests from their client base, Agility has added significant resources to its consulting offering which covers all stages of the clinical development process from regulatory strategy to electronic submission, including among other areas, expertise in chemistry, manufacturing, and controls (CMC), toxicology, and pharmacokinetics. Agility also includes executive level support and staffing in its services, with the capability to provide experienced people in positions such as Chief Medical Officer (CMO) or heads of Project Management, Biostatistics and Regulatory Affairs, on a temporary or contract basis. 

"Our goal is to provide guidance and proactive solutions for small and virtual biopharma and device companies so that their product development programs are successful within their timelines and budget constraints," says Marilyn Carlson, D.M.D., M.D., RAC, Vice President of Medical, Regulatory and Scientific Affairs at Agility.

Agility was founded in April 2012 with an experienced executive management team whose mission is to help small and virtual pre-clinical and clinical stage companies develop drugs and devices.  In addition to consulting, Agility provides customized full clinical trial services including project management, clinical operations, data management, biostatistics, medical, regulatory, and scientific affairs, medical writing and electronic source records (ESR). The Agility team has a true appreciation for the challenges virtual companies face in obtaining dedicated expertise they need. Agility has established operations in Carlsbad, CA. For more information, please visit www.agility-clinical.com.

Contact: Amy Zimmerman
A.Z. Communications
619-501-1875
amy@azcommunications.net


'/>"/>
SOURCE Agility Clinical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta to Showcase Revolutionary Agility Beam-shaping Innovation at Radiation Physics Annual Meeting
2. Austrian Medical Center Upgrades Cancer Treatment System, Improves Patient Care with Elektas Agility Beam-shaping Device
3. 90 Presentations at Leading Radiation Oncology Meeting Demonstrate the Breadth and Depth of Clinical Evidence for Accuray Technologies
4. Stemline Therapeutics Lead Clinical Candidate SL-401 Induces a Complete Response in a Patient with a Drug-Refractory Plasmacytoid Dendritic Cell Neoplasm
5. Arisaph Pharmaceuticals Reports Positive Results From Two Safety Clinical Trials For Its Niacin Analog (ARI-3037MO)
6. Greenphires ClinCard Technology Platform selected by top 5 pharmaceutical company for long-term global clinical trial
7. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
8. MEI Pharma Reports New Data Showing High Response Rates in Clinical Trial of Pracinostat and Azacitidine in Myelodysplastic Syndrome
9. Zafgen Announces Initiation of Phase 2a Clinical Development with Beloranib in Obesity
10. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
11. LABSCO Implements Leading-Edge Technology to Support Growth and Seize Opportunities in the Clinical Laboratory Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
(Date:4/27/2016)... PARIS , April 27, 2016 ... Year-Over-Year Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) ... today announced its sales for the first quarter ended ... business and the execution of its commercial strategy. ...
(Date:4/27/2016)... April 27, 2016 Transparency Market ... Devices Market - Global Industry Analysis, Size, Share, Growth, ... report, the global skincare devices market was valued at ... expand at a CAGR of 10.1% from 2015 to ... Browse the full Skincare Devices Market (Treatment Device - ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... April 28, 2016 , ... Cosmetic Town, an online plastic surgery community, ... forum section was recently revamped and upgraded to allow even more interaction between doctors ... the country. , According to the senior editor of Cosmetic Town, “We are excited ...
(Date:4/28/2016)... ... April 28, 2016 , ... Horizon ... collaborating with doctors and hospitals to make transformative changes in how health care ... therapy minds this week in discussing breakthroughs in cellular medicine to treat disease. ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... USA Medical Card reminds us that May ... (CDC), a stroke is the fourth leading cause of death in the United States; someone ... almost a quarter of them in individuals under 65 years old. A stroke is ...
(Date:4/28/2016)... PA (PRWEB) , ... April 28, 2016 , ... ... Browne, M.D. has been named a Top Doc in Physical Medicine and Rehabilitation ... conjunction with Castle Connolly Medical, Ltd. by randomly surveying physicians and medical leadership ...
(Date:4/28/2016)... ... April 28, 2016 , ... Denise McCormick Baich had written poetry dating back to her ... again much like a tsunami and took on a more spiritual tone. The desire to ... to do more with it than just file it away. Friends would ask her how ...
Breaking Medicine News(10 mins):